Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 6, Pages 1488-1496
Publisher
Springer Nature
Online
2014-02-19
DOI
10.1038/bjc.2014.50
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells
- (2013) S Sengupta et al. BRITISH JOURNAL OF PHARMACOLOGY
- c-Src Modulates Estrogen-Induced Stress and Apoptosis in Estrogen-Deprived Breast Cancer Cells
- (2013) P. Fan et al. CANCER RESEARCH
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study
- (2013) Rowan T. Chlebowski et al. JNCI-Journal of the National Cancer Institute
- Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer
- (2012) Catherine M. Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
- (2012) Garnet L Anderson et al. LANCET ONCOLOGY
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
- (2012) G M A Ajabnoor et al. Cell Death & Disease
- Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials
- (2011) Jordi Ginés et al. Clinical & Translational Oncology
- Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
- (2011) Nicholas J. Robert et al. Clinical Breast Cancer
- Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
- (2011) V. Beral et al. JNCI-Journal of the National Cancer Institute
- Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time
- (2011) E. A. Ariazi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells
- (2010) O Kutuk et al. CELL DEATH AND DIFFERENTIATION
- A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention
- (2009) V. Craig Jordan CANCER RESEARCH
- Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast Cancer
- (2009) Matthew J. Ellis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bim is reversibly phosphorylated but plays a limited role in paclitaxel cytotoxicity of breast cancer cell lines
- (2008) Matt Czernick et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- From endoplasmic-reticulum stress to the inflammatory response
- (2008) Kezhong Zhang et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now